These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 15194601)

  • 21. Efficacy and safety of atypical antipsychotics for behavioral symptoms of dementia among patients residing in long-term care.
    Sturm AS; Trinkley KE; Porter K; Nahata MC
    Int J Clin Pharm; 2018 Feb; 40(1):135-142. PubMed ID: 29189977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quetiapine versus risperidone in elderly patients with behavioural and psychological symptoms of dementia: efficacy, safety and cognitive function.
    Rainer M; Haushofer M; Pfolz H; Struhal C; Wick W
    Eur Psychiatry; 2007 Sep; 22(6):395-403. PubMed ID: 17482432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of atypical antipsychotics in elderly patients with dementia.
    Tariot PN; Profenno LA; Ismail MS
    J Clin Psychiatry; 2004; 65 Suppl 11():11-5. PubMed ID: 15264966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risperidone (depot) for schizophrenia.
    Sampson S; Hosalli P; Furtado VA; Davis JM
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD004161. PubMed ID: 27078222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The use of antipsychotics in patients with dementia].
    Forlenza OV; Cretaz E; Diniz BS
    Braz J Psychiatry; 2008 Sep; 30(3):265-70. PubMed ID: 18833428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy and safety of atypical antipsychotics for the treatment of dementia: a meta-analysis of randomized placebo-controlled trials.
    Ma H; Huang Y; Cong Z; Wang Y; Jiang W; Gao S; Zhu G
    J Alzheimers Dis; 2014; 42(3):915-37. PubMed ID: 25024323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Olanzapine for schizophrenia.
    Duggan L; Fenton M; Rathbone J; Dardennes R; El-Dosoky A; Indran S
    Cochrane Database Syst Rev; 2005 Apr; (2):CD001359. PubMed ID: 15846619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of Antipsychotics in Patients with Behavioral and Psychological Symptoms of Dementia: Results of a Spanish Delphi Consensus.
    Manzano-Palomo S; Agüera-Ortiz LF; García-Caballero A; Martínez-Raga J; Ojea-Ortega T; Sánchez-Valle R; Antón-Jiménez M; Monge-Argilés JA; Ramos-García I
    Dement Geriatr Cogn Disord; 2020; 49(6):573-582. PubMed ID: 33176326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Olanzapine for schizophrenia.
    Duggan L; Fenton M; Dardennes RM; El-Dosoky A; Indran S
    Cochrane Database Syst Rev; 2000; (2):CD001359. PubMed ID: 10796640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antidepressants for agitation and psychosis in dementia.
    Seitz DP; Adunuri N; Gill SS; Gruneir A; Herrmann N; Rochon P
    Cochrane Database Syst Rev; 2011 Feb; (2):CD008191. PubMed ID: 21328305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review.
    Seitz DP; Gill SS; Herrmann N; Brisbin S; Rapoport MJ; Rines J; Wilson K; Le Clair K; Conn DK
    Int Psychogeriatr; 2013 Feb; 25(2):185-203. PubMed ID: 23083438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chlorpromazine versus atypical antipsychotic drugs for schizophrenia.
    Saha KB; Bo L; Zhao S; Xia J; Sampson S; Zaman RU
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD010631. PubMed ID: 27045703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Profile of atypical-antipsychotics use in patients affected by dementia in the University Hospital of Ferrara.
    Chiabrando G; Bianchi S; Poluzzi E; Montanaro N; Scanavacca P
    Eur J Clin Pharmacol; 2010 Jul; 66(7):661-9. PubMed ID: 20464383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and Safety of Atypical Antipsychotics for Behavioral and Psychological Symptoms of Dementia Among Community Dwelling Adults.
    Trinkley KE; Sturm AM; Porter K; Nahata MC
    J Pharm Pract; 2020 Feb; 33(1):7-14. PubMed ID: 29695193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risperidone versus other atypical antipsychotic medication for schizophrenia.
    Gilbody SM; Bagnall AM; Duggan L; Tuunainen A
    Cochrane Database Syst Rev; 2000; (3):CD002306. PubMed ID: 10908551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risperidone: a review of its use in the management of the behavioural and psychological symptoms of dementia.
    Bhana N; Spencer CM
    Drugs Aging; 2000 Jun; 16(6):451-71. PubMed ID: 10939309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do atypical antipsychotics cause stroke?
    Herrmann N; Lanctôt KL
    CNS Drugs; 2005; 19(2):91-103. PubMed ID: 15697324
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.